Indefinite Delivery Contract W81XWH18D0016

The National Institute of Standards and Technology (NIST), a civilian federal agency, awarded a Blanket Purchase Agreement (BPA) contract to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The BPA allows NIST to quickly procure Illumina's proprietary sequencing systems, reagents, and consumables to support their genomic research and analysis needs. Under this BPA, NIST has issued multiple firm fixed price call orders to Illumina, with a total contract...

This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $992,022 IDC provides for the delivery of NextSeq 500 High Output Reagent Kits to support the FDA's nucleic acid sequencing needs, with no set-aside provisions. Three delivery orders have been issued against the IDC, valued at $38,896, $193,380, and $237,188 respectively, for the purchase of...

Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH). The IDC has a ceiling value of $92,416,478 and a period of performance through March 2, 2026. Under this IDC and associated delivery orders, Illumina will provide a range of its advanced sequencing instruments,...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of Reagent (Chemistry) Kits. The single-award IDC has a ceiling value of $19,500,000 and an ultimate completion date of September 14, 2022. Under this contract, the FDA has issued a series of firm fixed-price delivery orders to Illumina for the supply of various chemistry...

Neogen Corp holds a single-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract valued at $6,000,000 with the U.S. Department of Agriculture's Office of Administrative Services Procurement Management Branch, awarded on June 3, 2024, with an ultimate completion date of June 2, 2026. This contract was competitively awarded through full and open competition with no set-aside designation under solicitation 24Q0002, which sought pathogen screening technology to support the Food Safety and...

The NIH Clinical Center awarded a single-award Indefinite Delivery Contract valued at $1.25 million to Becton, Dickinson and Company (BD Biosciences division) effective January 1, 2025, through December 31, 2026, with options extending through 2029. This civilian agency contract procures BD instrumentation packages, reagent kits, quality control materials, and supplies specifically designed to support the Hematology Flow Cytometry Service at the NIH Clinical Center. The acquisition was conducted...

The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a single-award Blanket Purchase Agreement (BPA) to Qiagen, LLC, a foreign-owned for-profit manufacturer, to provide ONE STEP RT PCR KIT. The $49.2 million BPA has a period of performance through December 31, 2021. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia, has a history of delivering a range of products and services to...

The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 2, awarded a single-award Blanket Purchase Agreement (BPA) to Biomerieux Inc. on October 1, 2024, for the supply of VIDAS 3 reagents and consumables with a ceiling value of $166,910.52 and an ultimate completion date of March 31, 2026. The BPA is structured as a firm-fixed-price indefinite delivery vehicle that enables the VA to procure diagnostic consumables on an as-needed basis to support the continued...

This Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $243,308 single-award contract has a period of performance ending on June 4, 2013. Under this IDC, Illumina provides a range of genomic sequencing systems, consumables, and bioinformatics products to support research and...

Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin S.P.A., has been awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 4 (VISN 4), a civilian component of the Department of Veterans Affairs, to provide micro and immunoassay laboratory testing services and equipment. The contract, valued at $20,743.88 with an ultimate completion date of May 16, 2026, was awarded on March 24, 2026, without socioeconomic set-asides. As a specialized medical...